Journal article

A RISK-BENEFIT ASSESSMENT OF MOCLOBEMIDE IN THE TREATMENT OF DEPRESSIVE-DISORDERS

TR NORMAN, GD BURROWS

Drug Safety | ADIS INTERNATIONAL LTD | Published : 1995

DOI: 10.2165/00002018-199512010-00004

University of Melbourne Researchers

Citation metrics

9Web of Science
11Scopus

Keywords

Risk Assessment
Science & Technology
Pharmacology & Pharmacy
Benzamides
Moclobemide
Toxicology
Monoamine Oxidase Inhibitors
Life Sciences & Biomedicine
Humans
Antidepressive Agents
Depressive Disorder
Tyramine
Narcotics
Psychomotor Performance
Drug Synergism
Drug Interactions
Public, Environmental & Occupational Health
Blood Pressure